TP53 and gastric cancer: Our study cohort includes also tumors from the gastro-esophageal junction and distal esophagus, which share the molecular and morphological characteristics of intestinal-type gastric cancer, especially the TP53 mutant (CIN) and the EBV-/TP53WT/MMR-proficient (other) subtypes [4, 20].The expression was correlated with important clinical variables and different molecular subtypes of intestinal GC.